[Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection]. [electronic resource]
Producer: 20140904Description: 53 p. digitalISSN:- 1438-3276
- Antiviral Agents -- adverse effects
- Drug Therapy, Combination
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Heterocyclic Compounds, 3-Ring -- adverse effects
- Humans
- Interferons -- adverse effects
- Protease Inhibitors -- adverse effects
- Randomized Controlled Trials as Topic
- Ribavirin -- adverse effects
- Secondary Prevention
- Simeprevir
- Sofosbuvir
- Sulfonamides -- adverse effects
- Uridine Monophosphate -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.